What AI says about Recursion
Since Jul 5Updated Nov 3, 2026Based on 978 AI responses
Reviewed by Dimitry Apollonsky
AI summary
Recursion is a TechBio company that uses large proprietary datasets, automated wet-lab robotics, and the Recursion Operating System to identify drug targets and design molecules for oncology and rare diseases.
18%
of AI answers about Recursion and its rivals
- ChatGPT20%
- Google AI Mode15%
Markets where AI mentions Recursion
Topics where AI mentions Recursion
- AI picks mostMentioned in
- Which AI platform is best for identifying novel drug targets for a biotech?on this questionAI picks Recursion and 1 more about as often90%
Excerpts where Recursion appeared in the AI's answer
Google AI ModeSep 29, 2026, Google AI Mode Recursion Pharmaceuticals (Recursion OS): Best if you want a platform that maps biology through massive automated cellular imaging and phenomic data.
Google AI ModeSep 17, 2026, Google AI Mode Recursion Pharmaceuticals (Recursion OS): Best for industrial-scale high-content biology.
- Which AI-native platforms help small biotech teams compete with large pharma research groups?on this questionAI picks Recursion and 1 more about as often76%
Excerpts where Recursion appeared in the AI's answer
Google AI ModeSep 28, 2026, Google AI Mode Recursion Pharmaceuticals: Recursion merges automated, high-throughput biology with machine learning
Google AI ModeSep 16, 2026, Google AI Mode Recursion Pharmaceuticals combines high-throughput automated biology with massive cloud-based machine learning
- What AI tools help biotech teams prioritize compounds before expensive wet lab work?on this questionAI picks Schrödinger and 1 more about as often48%
Excerpts where Recursion appeared in the AI's answer
- We want to model toxicity and safety earlier in drug development. Which AI platforms are credible?on this questionAI picks Certara and 2 more about as often41%
Excerpts where Recursion appeared in the AI's answer
ChatGPTSep 26, 2026, ChatGPT Recursion / Valence Labs — strong for phenotypic, cellular and multimodal biology
Google AI ModeSep 18, 2026, Google AI Mode Recursion Pharmaceuticals : Utilizes an automated, tech-driven phenotypic discovery approach
- Our lab wants AI to propose molecules, design experiments, and learn from results. What discovery engines should we evaluate?on this questionAI picks Insilico Medicine and 1 more about as often25%
Excerpts where Recursion appeared in the AI's answer
Google AI ModeSep 12, 2026, Google AI Mode Recursion OS: If your lab leans heavily into high-throughput biology and phenotypic drug discovery, Recursion Pharmaceuticals offers an industrialized "lab-in-the-loop" ecosystem
ChatGPTAug 31, 2026, ChatGPT Recursion Pharmaceuticals - Best fit: biology-first discovery using large-scale phenomics, automation, and machine learning.
- We need automated lab planning and robotic execution tied to model feedback. What companies are building this?on this questionAI picks Opentrons and 1 more about as often27%
Excerpts where Recursion appeared in the AI's answer
Google AI ModeSep 18, 2026, Google AI Mode Recursion Pharmaceuticals operates via the Recursion OS , a massive integrated techbio platform.
ChatGPTSep 18, 2026, ChatGPT Recursion Pharmaceuticals — Combines biological experimentation, automation, and machine learning at scale.
How prominently AI mentions Recursion
- Named first6%
- 2nd or 3rd30%
- Later63%
How AI rates Recursion
Common descriptions
massive · industrial-scale · large-scale · automated experimentation · automated high-throughput imaging
Tone of AI’s statements about Recursion
- Positive59%
- Neutral37%
- Mixed3%
- Negative1%
Recursion in AI answers
Sources AI cites
- Your site28%
- Pioneering AI Drug Discovery | Recursion (opens in a new tab) · 12%
- Recursion OS: The AI product engine to industrialize drug discovery (opens in a new tab) · 9%
- Pioneering AI Drug Discovery | Recursion (opens in a new tab) · 3%
- Unlocking the First Neuroscience Target for the Recursion and Genentech Collaboration (opens in a new tab) · 2%
- Our Unique Approach to AI Drug Discovery | Recursion (opens in a new tab) · 1%
- Full Transcript of Recursion's Second Quarter 2026 Earnings Call (opens in a new tab) · 1%
- FAQ (opens in a new tab) · 1%
- 6%
- Checking your browser - reCAPTCHA (opens in a new tab) · 3%
- Digital Alchemy: The Rise of Machine and Deep Learning in Small-Molecule Drug Discovery - PMC (opens in a new tab) · 1%
- Deep Generative AI for Multi-Target Therapeutic Design: Toward Self-Improving Drug Discovery Framework (opens in a new tab) · 1%
- AI-Driven Enzyme Engineering: Emerging Models and Next-Generation Biotechnological Applications - PMC (opens in a new tab) · 1%
- AI accelerate the identification of druggable targets by 3D structures of proteins and compounds - PMC (opens in a new tab) · 1%
- AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor (opens in a new tab) · 1%
- 5%
- AI Tools in Pharma R&D: 10 Essential Platforms for 2026 | IntuitionLabs (opens in a new tab) · 1%
- AI in Biotech: A Guide to Data Infrastructure Readiness | IntuitionLabs (opens in a new tab) · 1%
- AI Drug Discovery: Perceptic's Unified Pharma R&D Platform (opens in a new tab) · 1%
- AI in Pharma: 15 Startups Accelerating Drug Discovery | IntuitionLabs (opens in a new tab) · 1%
- The Modern Biotech Lab: A Guide to Automation, AI & Data (opens in a new tab) · 1%
- AI Patents in Pharma: Ranking the Top 25 Companies (2025) (opens in a new tab) · 1%
- IntuitionLabs - AI Software for Pharma & Biotech (opens in a new tab) · 1%
- 5%
- Top 12 AI Drug Discovery Companies in 2026, Ranked (opens in a new tab) · 3%
- 19 Pharma Startups Shaping AI-Driven Drug Discovery (opens in a new tab) · 1%
- 19 Pharma Startups Shaping AI-Driven Drug Discovery (opens in a new tab) · 1%
- Top AI Drug Discovery Companies 2026 | AI in Pharma (opens in a new tab) · 1%
- 5%
- Leading artificial intelligence–driven drug discovery platforms (opens in a new tab) · 3%
- Leading artificial intelligence–driven drug discovery platforms (opens in a new tab) · 1%
- AI-driven multi-scale target analysis of traditional Chinese medicine: From the pharmacological effects of single compounds to the synergistic mechanisms of formulae (opens in a new tab) · 1%
- 4%
- The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation - DrugPatentWatch – Transform Data into Market Domination (opens in a new tab) · 1%
- AI Cuts Drug Discovery Time in Half. Here’s the Patent Trail Proving It. (opens in a new tab) · 1%
- Algorithms Don’t Own Patents: How to Win the AI Drug Race (opens in a new tab) · 1%
- AI in Drug Discovery: The Complete Technical and IP Strategy Guide for Pharma Executives (opens in a new tab) · 1%
- AI Drug Patent Strategy: How Artificial Intelligence Is Reshaping Pharmaceutical IP Portfolios, Prior Art, and Patent Litigation (opens in a new tab) · 1%
- 3%
- AI is accelerating drug development and innovation (opens in a new tab) · 1%
- We’re Recursion and we’re using AI to decode biology and industrialize drug discovery! : r/IAmA (opens in a new tab) · 1%
- Ai in bio (opens in a new tab) · 1%
- 💊𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝟱 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗔𝗜 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 🤖 (opens in a new tab) · 1%

